Published in FEBS Lett on June 02, 1980
Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A (1982) 2.89
Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family. Proc Natl Acad Sci U S A (1981) 1.63
Vasoactive intestinal peptide enhances aromatase activity in the neonatal rat ovary before development of primary follicles or responsiveness to follicle-stimulating hormone. Proc Natl Acad Sci U S A (1987) 0.88
The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor. Biochem J (1985) 0.83
Vasoactive intestinal polypeptide regulation of rabbit renal adenylate cyclase activity in vitro. J Physiol (1987) 0.78
Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum. Gut (1984) 0.78
Excitatory actions of peptide histidine isoleucine on thalamic relay neurons. Neuropharmacology (2008) 0.77
Peptide histidine isoleucine: a secretagogue in human jejunum. Gut (1984) 0.75
Stimulatory effect of the intestinal peptide PHI on glycogenolysis and gluconeogenesis in isolated rat hepatocytes. Biochem J (1983) 0.75
Polypeptide with broad biological activity: isolation from small intestine. Science (1970) 4.14
Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (1982) 4.06
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica. Nature (1966) 3.17
Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett (1983) 3.12
Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A (1982) 2.89
Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem (1968) 2.72
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A (1989) 2.59
Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem (1972) 2.59
Structure of porcine secretin. The amino acid sequence. Eur J Biochem (1970) 2.44
Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature (1980) 2.31
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev (1998) 2.30
Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand (1982) 2.23
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Molecular cloning of a brain-specific calcium/calmodulin-dependent protein kinase. Proc Natl Acad Sci U S A (1987) 2.13
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (1987) 2.09
N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett (1980) 2.04
Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci U S A (1982) 2.03
Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem (1997) 2.00
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A (1980) 2.00
Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem (1991) 1.95
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene (1999) 1.82
Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J (2000) 1.75
Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia (1980) 1.74
Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line. J Immunol Methods (1993) 1.72
Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination. Eur J Biochem (1974) 1.71
Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse. FEBS Lett (1972) 1.71
Structural homologies between prealbumin, gastrointestinal prohormones and other proteins. Nature (1981) 1.69
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family. Proc Natl Acad Sci U S A (1981) 1.63
A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett (1984) 1.63
The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs. Can J Physiol Pharmacol (1971) 1.62
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res (1996) 1.59
Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta (1999) 1.56
Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers. Anticancer Drugs (1997) 1.53
Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides (1984) 1.51
Cholecystokinin and pancreozymin, one single hormone? Acta Physiol Scand (1966) 1.51
Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A (1978) 1.47
Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer (1995) 1.43
Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience (1984) 1.41
Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors. Cancer Res (1982) 1.40
Isolation of aspartyl-phenylalanine amide from cholecystokinin-pancreozymin. Biochem Biophys Res Commun (1967) 1.37
Preliminary report: role of peptide YY in defence against diarrhoea. Lancet (1990) 1.37
Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem (1988) 1.34
Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Oncogene (2007) 1.32
Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide. Lancet (1983) 1.31
Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. J Cell Physiol (1985) 1.30
Preparation of highly active enterogastrone. Can J Physiol Pharmacol (1969) 1.30
Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature (1970) 1.30
Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regul Pept (1983) 1.29
Distribution of galanin immunoreactivity in the central nervous system and the responses of galanin-containing neuronal pathways to injury. Neuroscience (1985) 1.27
PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J Clin Invest (2001) 1.27
Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes (1974) 1.27
Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci U S A (1994) 1.24
A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon. Nature (1987) 1.24
Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells. Oncogene (2008) 1.24
Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene (2002) 1.22
Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tissue Res (1985) 1.22
Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A (1978) 1.21
Mucin gene expression in human embryonic and fetal intestine. Gut (1998) 1.19
Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology (1985) 1.18
The role of bile acids in carcinogenesis. Mutat Res (2001) 1.17
Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett (1983) 1.17
Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase. Eur J Biochem (1988) 1.16
On the biological assay of secretin. The reference standard. Acta Physiol Scand (1966) 1.15
Further investigations of intestinal hormonal polypeptides. Clin Endocrinol (Oxf) (1976) 1.15
Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene (1996) 1.15
Excitation transfer in complexes of horse liver alcohol dehydrogenase. Arch Biochem Biophys (1971) 1.14
A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29. J Biol Chem (1995) 1.14
Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Biochem Biophys Res Commun (1998) 1.13
Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes (1985) 1.12
Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer (2001) 1.12
Conformational studies on the pancreatic polypeptide hormone family. Eur J Biochem (1984) 1.11
Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides (1982) 1.11
[The effects of perfusion and amino acid ingestion in glucagonenemia]. Journ Annu Diabetol Hotel Dieu (1967) 1.11
Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer (2000) 1.11
Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer (1999) 1.10
Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol (1970) 1.10
Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines. Biochem Biophys Res Commun (2000) 1.10
Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2. Oncogene (2007) 1.09
Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP. Mol Pharmacol (1982) 1.08
Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun (1997) 1.08